Jeremy M. Levin

Insider Reports History

Entity
Individual
Signature
/s/ Danielle Mann for Jeremy M. Levin by PoA
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy M. Levin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ovid Therapeutics Inc. CEO, Director Common Stock 3.62M $9.98M $2.76 Mar 18, 2024 Direct
Ovid Therapeutics Inc. CEO, Director Common Stock 35.5K $97.9K $2.76 Mar 18, 2024 Indirect
Ovid Therapeutics Inc. CEO, Director Stock Option (Right to Buy) 700K Feb 22, 2024 Direct

Insider Reports Filed by Jeremy M. Levin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OVID Ovid Therapeutics Inc. Mar 18, 2024 1 $50.4K 4 Mar 20, 2024 CEO, Director
OVID Ovid Therapeutics Inc. Feb 22, 2024 1 $0 4 Feb 26, 2024 CEO, Director
OVID Ovid Therapeutics Inc. Dec 4, 2023 2 $0 4 Dec 6, 2023 CEO, Director
OVID Ovid Therapeutics Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 CEO, Director, 10%+ Owner
OVID Ovid Therapeutics Inc. Apr 8, 2022 1 $0 4 Apr 12, 2022 CEO, Director, 10%+ Owner
OVID Ovid Therapeutics Inc. Feb 3, 2022 1 $0 4 Feb 4, 2022 CEO, Director, 10%+ Owner
OVID Ovid Therapeutics Inc. Oct 8, 2019 1 $0 4/A Feb 14, 2024 CEO, Director